Adverse Events Clinical Trials

24 recruitingLast updated: June 18, 2026

There are 24 actively recruiting adverse events clinical trials across 13 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, Berlin, Germany. Updated daily from ClinicalTrials.gov.


Adverse Events Trials at a Glance

24 actively recruiting trials for adverse events are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Boston, Beijing, and Berlin. Lead sponsors running adverse events studies include University of Queensland, Boston Children's Hospital, and Ballarat Health Services.

Browse adverse events trials by phase

Treatments under study

About Adverse Events Clinical Trials

Looking for clinical trials for Adverse Events? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adverse Events trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adverse Events clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting

Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events

OncologyPatient SafetySerious Adverse Events+1 more
St Vincent's University Hospital, Ireland100 enrolled1 locationNCT07592234
Recruiting

CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation

Adverse EventsIntubation Complication
Thomas Riva105,000 enrolled8 locationsNCT05804188
Recruiting

Factors for Prolonged Hospital Stays in Patients Undergoing ERCP

Post-ERCP Adverse EventsERCP Complications
Air Force Military Medical University, China504 enrolled2 locationsNCT07568626
Recruiting
Phase 4

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

Perioperative Respiratory Adverse EventsHigh-RiskRespiratory Hypersensitivity+2 more
Sun Yat-sen University204 enrolled2 locationsNCT06624696
Recruiting
Not Applicable

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

Health DisparitiesPatient SafetyQuality Improvement+3 more
Boston Children's Hospital656 enrolled1 locationNCT05407129
Recruiting

Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III

Adverse EventsAirway Complication of Anesthesia
Insel Gruppe AG, University Hospital Bern40,000 enrolled5 locationsNCT06117176
Recruiting

Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

Immune-related Adverse Events
Peking Union Medical College Hospital500 enrolled1 locationNCT07453342
Recruiting
Not Applicable

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Quality of LifeObjective Response RatePathological Complete Remission+1 more
The Second Hospital of Shandong University25 enrolled1 locationNCT07430579
Recruiting

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Solid TumorImmune-related Adverse EventsImmunotherapy Toxicity
Shantou University Medical College940 enrolled6 locationsNCT07357636
Recruiting

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

CancerCancer;Cardiovascular;Adverse Events
Sixth Affiliated Hospital, Sun Yat-sen University5,000 enrolled1 locationNCT07058454
Recruiting

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Solid TumorsSjogren SyndromeImmune-related Adverse Events+3 more
Hospital Universitario Araba300 enrolled1 locationNCT07249060
Recruiting
Phase 4

Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.

Perioperative Respiratory Adverse EventsAnesthesia Outcomes
Telethon Kids Institute200 enrolled1 locationNCT07000877
Recruiting

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

CancerImmune-Mediated HepatitisImmune-related Adverse Events
University Hospital, Basel, Switzerland63 enrolled2 locationsNCT07167251
Recruiting
Phase 1Phase 2

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

MalignancyImmune-related Adverse Events
Brigham and Women's Hospital100 enrolled2 locationsNCT06789601
Recruiting
Not Applicable

ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery

Adverse EventsSpine DeformityBone Graft; Complications
Rigshospitalet, Denmark240 enrolled1 locationNCT05038527
Recruiting

Supplemental Tackifier to Intravenous Catheter dressings to Keep intact Year-round in Kids (the STICKY Kids trial).

Central venous access device related adverse eventsCentral venous access device dressing complications
University of Queensland104 enrolled1 locationACTRN12625000137493
Recruiting

Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients

PD-1Immune-related Adverse Events
Guohui Li100 enrolled1 locationNCT04840355
Recruiting

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

ImmunotherapyImmune-related Adverse EventsPneumonitis, Interstitial
Universitaire Ziekenhuizen KU Leuven60 enrolled1 locationNCT04807127
Recruiting

Risk Factors and Risk Grading Prediction of Perioperative Respiratory Adverse Events in Children

Perioperative Respiratory Adverse Events
Sichuan Provincial People's Hospital600 enrolled1 locationNCT06354569
Recruiting
Not Applicable

Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS

StressChild DevelopmentAdverse Events+2 more
Ostergotland County Council, Sweden126 enrolled1 locationNCT05709392